GSK's Hal Barron On R&D Progress At Two-Year Mark
R&D Chief Says Doubters Are Coming Round
Executive Summary
Chief scientific officer at GSK, Hal Barron, talks about winning hearts and minds of 10,000 R&D employees, and adopting practices from acquired company Tesaro.